Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
DomainSyntaxin-6_N

STX10 STX6

4.09e-0521202IPR015260
DomainSyntaxin-6_N

STX10 STX6

4.09e-0521202PF09177
Domain-

RASGRF1 SHC4 DGKD PTPN21 PTPN4 ELMO2 RABGAP1L NGEF ARHGAP25 PLCB4 PLD1

4.44e-05391120112.30.29.30
DomainPH_dom-like

RASGRF1 SHC4 DGKD PTPN21 PTPN4 ELMO2 RABGAP1L NGEF ARHGAP25 PLCB4 PLD1

9.55e-0542612011IPR011993
Pubmed

Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.

ASXL1 RALGAPB TOGARAM1 SCRN1 ZNF462 SULF2 NAV2 MACF1 KDM2A SMG6

1.05e-082251261012168954
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

MARK1 TOGARAM1 DGKD CEP350 ZNF462 PIKFYVE CCDC88C CDK13 SAFB2 MACF1 KDM2A ARHGAP25 MBD5

3.18e-084931261315368895
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

GPRASP1 FLNA ANK3 MARK1 DTNA VPS33A HNRNPM SCRN1 RPS24 LRP1B KCNB1 MTHFD1 SPHKAP RABGAP1L MACF1 RIMS1 ATP5F1B

8.20e-0711391261736417873
Pubmed

A human MAP kinase interactome.

FLNA ANK3 HNRNPM LAMA4 NUP214 POGZ CEP350 NAV2 MACF1 KDM2A MBD5

1.70e-064861261120936779
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

ASXL1 RALGAPB NUP214 POGZ URB2 BAZ2A SGSM2 SPHKAP RABGAP1L MACF1

2.49e-064071261012693553
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

FLNA ANXA11 BTAF1 NUP214 LARS2 PIKFYVE CCDC88C FAM20C EHBP1L1 CDK13 SGSM2 NAV2 ZER1 MBD5 PLXNA1 SMG6

2.62e-0611051261635748872
Pubmed

Laser capture microdissection and cDNA array analysis for identification of mouse KIAA/FLJ genes differentially expressed in the embryonic dorsal spinal cord.

NUP214 BAZ2A NAV2 MACF1

2.70e-0627126419026994
Pubmed

New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.

MARK1 HNRNPM SRP9 DGKD RPS24 ZNF462 CCDC88C SPAG17 DYNC1LI2 ATP5F1B SMG6

2.86e-065131261125798074
Pubmed

Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.

FLNA ASXL1 RALGAPB PTPN4 BRCA1 BAZ2A PNMA2 LRP2 RIMS1

3.40e-06329126917474147
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

VIL1 FLNA FAM114A1 DTNA HNRNPM SRP9 ABCF2 PTPN21 SPATC1 BRCA1 CDK13 SAFB2 NAV2 MACF1 RIMS1 SPAG17 ERICH6 ATP5F1B

4.72e-0614421261835575683
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

FLNA RALGAPB BTAF1 NUP214 POGZ SNX33 ECPAS BAZ2A CDK13 SAFB2 RIMS1 PARD3 DYNC1LI2

5.05e-067741261315302935
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

ANK3 DTNA TOM1 RALGAPB BTAF1 ECPAS ZNF462 PTPN4 CDK13 SGSM2 NGEF MACF1 KDM2A PLCB4 RIMS1 PARD3 MBD5 SMG6

7.32e-0614891261828611215
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

FLNA HNRNPM ABCF2 DGKD RPS24 NUP214 POGZ SNX33 URB2 POLR1D BAZ2A MTHFD1 SAFB2 MACF1 KDM2A PARD3 ATP5F1B

8.17e-0613531261729467282
Pubmed

A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies.

VPS33A HNRNPM NUP214 GVINP1 SGSM2 RP1 DYNC1LI2 ATP5F1B

9.79e-06284126829459677
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

GPRASP1 ANK3 HNRNPM ZNF462 CCDC88C PTPRD KCNB1 SPHKAP NGEF SAFB2 MACF1 RIMS1 PARD3 SMG6

1.11e-059631261428671696
Pubmed

Genome-wide association scan of the time to onset of attention deficit hyperactivity disorder.

ADAMTS2 SULF2 NAV2

1.29e-0513126318937294
Pubmed

Characterization of Lhx9, a novel LIM/homeobox gene expressed by the pioneer neurons in the mouse cerebral cortex.

LHX9 LHX2

1.30e-052126210330499
Pubmed

Exome sequencing reveals DNMT3A and ASXL1 variants associate with progression of chronic myeloid leukemia after tyrosine kinase inhibitor therapy.

ASXL1 DNMT3A

1.30e-052126228667884
Pubmed

ELMO recruits actin cross-linking family 7 (ACF7) at the cell membrane for microtubule capture and stabilization of cellular protrusions.

ELMO2 MACF1

1.30e-052126223184944
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

FAM114A1 DTNA LAMA4 ABCF2 DGKD ZNF711 ZNF462 MACF1 KDM2A PARD3

1.43e-054971261023414517
Pubmed

A high-throughput approach for measuring temporal changes in the interactome.

FLNA FAM114A1 TOM1 HNRNPM SRP9 SCRN1 ABCF2 RPS24 ECPAS EHBP1L1 MTHFD1 PNMA2 TOMM34 MACF1 GOT1 DYNC1LI2 ATP5F1B

2.08e-0514551261722863883
Pubmed

Comprehensive identification of phosphorylation sites in postsynaptic density preparations.

MARK1 KCNB1 CTNNA3 NGEF SAFB2 MACF1 RIMS1

2.25e-05231126716452087
Pubmed

Defining the membrane proteome of NK cells.

PI4K2B FLNA DPY19L1 ANXA11 HNRNPM ABCF2 RPS24 ECPAS CEP350 EHBP1L1 MTHFD1 TOMM34 PLD1 DYNC1LI2 ATP5F1B

2.26e-0511681261519946888
Pubmed

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

ANK3 MARK1 DTNA RALGAPB ELMO2 MACF1 PARD3 STX10 STX6

2.42e-05421126936976175
Pubmed

Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.

ANXA11 DGKD ZNF462 PTPN4 MTHFD1 RABGAP1L PLCB4 PARD3 MBD5 SMG6

2.71e-055361261015840001
Pubmed

Exchangeable gene trap using the Cre/mutated lox system.

ANXA11 DGKD ZNF462 PTPN4 MTHFD1 RABGAP1L PLCB4 PARD3 MBD5 SMG6

2.80e-055381261010512203
Pubmed

SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.

FLNA HNRNPM RPS24 NUP214 BRCA1 KDM2A DNMT3A

3.72e-05250126733536335
Pubmed

Protein deep sequencing applied to biobank samples from patients with pancreatic cancer.

BAZ2A CDK13

3.90e-053126225216700
Pubmed

[Relationship between DTA Mutations and Thromboembolism in Patients with Myeloproliferative Neoplasms].

ASXL1 DNMT3A

3.90e-053126238926973
Pubmed

Epigenetic Changes in Neoplastic Mast Cells and Potential Impact in Mastocytosis.

ASXL1 DNMT3A

3.90e-053126233803981
Pubmed

Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east Asian cohort study.

ASXL1 DNMT3A

3.90e-053126238231881
Pubmed

Curcumin induces re‑expression of BRCA1 and suppression of γ synuclein by modulating DNA promoter methylation in breast cancer cell lines.

BRCA1 DNMT3A

3.90e-053126232020216
Pubmed

Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease.

ASXL1 DNMT3A

3.90e-053126234576030
Pubmed

TRIM44 promotes BRCA1 functions in HR repair to induce Cisplatin Chemoresistance in Lung Adenocarcinoma by Deubiquitinating FLNA.

FLNA BRCA1

3.90e-053126235541909
Pubmed

Par3 and dynein associate to regulate local microtubule dynamics and centrosome orientation during migration.

PARD3 DYNC1LI2

3.90e-053126219540120
Pubmed

Interaction with BRCA2 suggests a role for filamin-1 (hsFLNa) in DNA damage response.

FLNA BRCA1

3.90e-053126211602572
Pubmed

Genome-wide association study of copy number variations (CNVs) with opioid dependence.

PTPRD CTNNA3

3.90e-053126225345593
Pubmed

Measurable residual disease of canonical versus non-canonical DNMT3A, TET2, or ASXL1 mutations in AML at stem cell transplantation.

ASXL1 DNMT3A

3.90e-053126234267355
Pubmed

IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution.

ASXL1 DNMT3A

3.90e-053126224115220
Pubmed

HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults.

ASXL1 DNMT3A

3.90e-053126234099923
Pubmed

Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair.

FLNA HNRNPM NUP214 POGZ CEP350 BRCA1 MTHFD1 ATP5F1B

5.00e-05357126837059091
Pubmed

Gsk3β and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease.

HNRNPM ABCF2 RPS24 SNX33 ZNF462 CCDC88C MTHFD1 MBD5 ANGPTL7

5.06e-05463126927503909
Pubmed

Characterization of cDNA clones in size-fractionated cDNA libraries from human brain.

POGZ CEP350 RABGAP1L MACF1

5.21e-055612649455484
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

ANK3 DTNA HNRNPM ABCF2 RPS24 NUP214 ECPAS MTHFD1 MACF1 PARD3 ATP5F1B

5.63e-057081261139231216
Pubmed

FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.

FLNA RALGAPB HNRNPM ABCF2 RPS24 POGZ RNF214 MTHFD1 MACF1 ATP5F1B

7.06e-056011261033658012
Pubmed

Expression of the LIM-homeodomain gene Lmx1a (dreher) during development of the mouse nervous system.

LHX9 LHX2

7.78e-054126212351192
Pubmed

Trans-Golgi network syntaxin 10 functions distinctly from syntaxins 6 and 16.

STX10 STX6

7.78e-054126216154903
Pubmed

Transcription factor Lhx2 is necessary and sufficient to suppress astrogliogenesis and promote neurogenesis in the developing hippocampus.

LHX9 LHX2

7.78e-054126221690374
Pubmed

A VE-cadherin-PAR3-α-catenin complex regulates the Golgi localization and activity of cytosolic phospholipase A(2)α in endothelial cells.

CTNNA3 PARD3

7.78e-054126222398721
Pubmed

Alternative LIM homeodomain splice variants are dynamically regulated at key developmental steps in vertebrates.

LHX9 LHX2

7.78e-054126235247020
Pubmed

Lhx9: a novel LIM-homeodomain gene expressed in the developing forebrain.

LHX9 LHX2

7.78e-05412629880598
Pubmed

Identification of Filamin A as a BRCA1-interacting protein required for efficient DNA repair.

FLNA BRCA1

7.78e-054126220305393
Pubmed

DNA methyltransferase 1/3a overexpression in sporadic breast cancer is associated with reduced expression of estrogen receptor-alpha/breast cancer susceptibility gene 1 and poor prognosis.

BRCA1 DNMT3A

7.78e-054126224464625
Pubmed

Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis.

ASXL1 DNMT3A

7.78e-054126222905207
Pubmed

Zic2-dependent axon midline avoidance controls the formation of major ipsilateral tracts in the CNS.

LHX9 LHX2 PLXNA1

7.80e-0523126324360543
Pubmed

E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.

CCDC170 VIL1 HNRNPM CPT1B ECPAS SPATC1 FAM20C CDH20 MTHFD1 SCN3A LRP2

7.95e-057361261129676528
Pubmed

A genomic atlas of mouse hypothalamic development.

RASGRF1 ADAMTS2 LHX9 ZNF462 TBX19 LHX2

1.07e-04205126620436479
Pubmed

Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.

CCDC88C CTNNA3 LRP2 RP1 RIMS1 ATP5F1B

1.16e-04208126633230847
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

ANK3 HNRNPM MUC16 CEP350 BRCA1 MTHFD1 IFFO2 TOMM34 PLD1 PARD3 DYNC1LI2

1.28e-047771261135844135
Pubmed

Expression of major guidance receptors is differentially regulated in spinal commissural neurons transfated by mammalian Barh genes.

LHX9 LHX2

1.29e-045126220599893
Pubmed

Cooperating gene mutations in childhood acute myeloid leukemia with special reference on mutations of ASXL1, TET2, IDH1, IDH2, and DNMT3A.

ASXL1 DNMT3A

1.29e-045126223365461
Pubmed

Structural basis for the interaction of the Golgi-Associated Retrograde Protein Complex with the t-SNARE Syntaxin 6.

STX10 STX6

1.29e-045126223932592
Pubmed

Association analysis of 528 intra-genic SNPs in a region of chromosome 10 linked to late onset Alzheimer's disease.

ANK3 CTNNA3

1.29e-045126218163421
Pubmed

Identification of gene products suppressed by human immunodeficiency virus type 1 infection or gp120 exposure of primary human astrocytes by rapid subtraction hybridization.

RASGRF1 SRP9

1.29e-045126212775420
Pubmed

Properly formed but improperly localized synaptic specializations in the absence of laminin alpha4.

DTNA LAMA4

1.29e-045126211369940
Pubmed

Differential expression of LIM-homeodomain factors in Cajal-Retzius cells of primates, rodents, and birds.

LHX9 LHX2

1.29e-045126219923199
Pubmed

Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium.

MTHFD1 DNMT3A

1.29e-045126220570913
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

MARK1 HNRNPM SRP9 POGZ ZNF462 POLR1D LHX2 EHBP1L1 SULF2 SAFB2 MACF1 DYNC1LI2 DNMT3A

1.58e-0410821261338697112
Pubmed

Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.

FLNA ANK3 TRIM4 VPS33A HNRNPM RPS24 ECPAS MTHFD1 MACF1 SPAG17 ATP5F1B

1.78e-048071261130575818
Pubmed

Complementary quantitative proteomics reveals that transcription factor AP-4 mediates E-box-dependent complex formation for transcriptional repression of HDM2.

BTAF1 ZNF462 BRCA1 NGEF

1.81e-0477126419505873
Pubmed

Genome-wide association analysis of gender differences in major depressive disorder in the Netherlands NESDA and NTR population-based samples.

SHC4 PARD3

1.93e-046126221621269
Pubmed

BMP type I receptor complexes have distinct activities mediating cell fate and axon guidance decisions.

LHX9 LHX2

1.93e-046126218272594
Pubmed

Co-expression of several human syntaxin genes in neutrophils and differentiating HL-60 cells: variant isoforms and detection of syntaxin 1.

STX10 STX6

1.93e-046126210080545
Pubmed

Network organization of the human autophagy system.

FLNA DNAAF4 VPS33A ECPAS FREM1 RABGAP1L SAFB2 STX6

2.01e-04437126820562859
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

TRIM4 HNRNPM SRP9 POGZ ZNF711 SULF2 BRCA1 BAZ2A PNMA2 LRP2 MACF1 PLD1 PARD3

2.14e-0411161261331753913
Pubmed

ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.

POGZ BRCA1 BAZ2A KDM2A DNMT3A

2.24e-04150126528242625
Pubmed

A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.

FLNA DTNA ABCF2 NUP214 EYA2 PTPN21 ECPAS PTPN4 PTPRD PNMA2 TOMM34 ATP5F1B

2.28e-049741261228675297
Pubmed

Tagging genes with cassette-exchange sites.

ZNF462 RABGAP1L SAFB2 NAV2 MACF1 PLXNA1 SMG6

2.29e-04335126715741177
Pubmed

Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.

VIL1 NUP214 FREM1 CTNNA3 MACF1

2.38e-04152126534299191
Pubmed

Genetic variants associated with disordered eating.

NT5C1B CEP350 SPHKAP ZER1

2.42e-0483126423568457
Pubmed

Proximity labelling identifies pro-migratory endocytic recycling cargo and machinery of the Rab4 and Rab11 families.

SCRN1 EHBP1L1 RABGAP1L PLCB4 STX10 STX6 DYNC1LI2

2.46e-04339126737232246
Pubmed

Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.

BTAF1 POGZ ECPAS POLR1D BAZ2A SAFB2 KDM2A

2.55e-04341126732971831
Pubmed

Gbx2 regulates thalamocortical axon guidance by modifying the LIM and Robo codes.

LHX9 LHX2

2.70e-047126223136391
Pubmed

The mouse Dreher gene Lmx1a controls formation of the roof plate in the vertebrate CNS.

LHX9 LHX2

2.70e-047126210693804
Pubmed

Progenitors of dorsal commissural interneurons are defined by MATH1 expression.

LHX9 LHX2

2.70e-04712629449674
Pubmed

GATA4/FOG2 transcriptional complex regulates Lhx9 gene expression in murine heart development.

LHX9 LHX2

2.70e-047126218577233
Pubmed

p62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic Factors.

RPS24 CEP350 PARD3 DYNC1LI2 ATP5F1B

2.93e-04159126530581152
Pubmed

140 mouse brain proteins identified by Ca2+-calmodulin affinity chromatography and tandem mass spectrometry.

PIKFYVE NGEF TOMM34 PLXNA1 DYNC1LI2

3.29e-04163126516512683
Pubmed

Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex.

FLNA ELMO2 MACF1

3.30e-0437126327565344
Pubmed

A role for BMP heterodimers in roof plate-mediated repulsion of commissural axons.

LHX9 LHX2

3.59e-048126212741987
Pubmed

Type Ib BMP receptors mediate the rate of commissural axon extension through inhibition of cofilin activity.

LHX9 LHX2

3.59e-048126223250207
Pubmed

A molecular program for contralateral trajectory: Rig-1 control by LIM homeodomain transcription factors.

LHX9 LHX2

3.59e-048126218701067
Pubmed

Ptbp2 represses adult-specific splicing to regulate the generation of neuronal precursors in the embryonic brain.

ANK3 CEP350 SPHKAP

3.86e-0439126322802532
Pubmed

Prediction of the coding sequences of unidentified human genes. IV. The coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by analysis of cDNA clones from human cell line KG-1.

DGKD URB2 SAFB2

4.48e-044112638590280
Pubmed

Quantitative nanoproteomics for protein complexes (QNanoPX) related to estrogen transcriptional action.

FLNA HNRNPM RPS24

4.48e-0441126319805454
Pubmed

ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells.

FLNA DPY19L1 HNRNPM ABCF2 MTHFD1 ATP5F1B

4.51e-04268126633024031
Pubmed

CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.

FLNA HNRNPM RPS24 NUP214 ECPAS BRCA1 TRNAU1AP MTHFD1

4.56e-04494126826831064
Pubmed

EMX2 regulates sizes and positioning of the primary sensory and motor areas in neocortex by direct specification of cortical progenitors.

LHX9 LHX2

4.61e-049126215294144
Pubmed

Molecular markers of neuronal progenitors in the embryonic cerebellar anlage.

LHX9 LHX2

4.61e-049126217122047
Pubmed

Selective requirement of Pax6, but not Emx2, in the specification and development of several nuclei of the amygdaloid complex.

LHX9 LHX2

4.61e-049126215758185
InteractionAPC interactions

FLNA HNRNPM LAMA4 NUP214 SULF2 CTNNA3 NAV2 MACF1 RP1 PARD3 MBD5 RPA4

4.73e-0638912312int:APC
CoexpressionGSE3982_MEMORY_CD4_TCELL_VS_TH2_UP

ASXL1 RASGRF1 RALGAPB DGKD CEP350 CPQ SGSM2 MACF1

5.01e-061961268M5381
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DPY19L1 LRP1B LHX2 SULF2 SPHKAP NGEF ARHGAP25

9.56e-0718412679cc5c588f7c6631b3fb8a522214a09ca32947e72
ToppCellCOVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations)

ANK3 EYA2 PTPRD NAV2 RP1 RIMS1 PARD3

9.91e-071851267cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ANK3 DTNA ZNF462 PTPRD LRP2 PLCB4 PARD3

1.03e-061861267b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DPY19L1 LAMA4 LRP1B SULF2 NAV2 PLCB4 RP1

1.14e-0618912678c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DPY19L1 LAMA4 LRP1B SULF2 NAV2 PLCB4 RP1

1.14e-0618912675d902a4660a27548764bf04c6de152b565da835c
ToppCellrenal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group

ANK3 PTPRD RABGAP1L LRP2 MACF1 PARD3 MBD5

1.27e-061921267e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCellCOPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class

ANK3 NAV2 MACF1 PLCB4 RP1 PARD3 SPAG17

1.46e-061961267af4cdc61830685a888a1209826c23bcf54a43084
ToppCellCOPD-Multiplet|COPD / Disease state, Lineage and Cell class

ANK3 NAV2 MACF1 PLCB4 RP1 PARD3 SPAG17

1.46e-0619612676d02d494196e3f857d53eea46d9419690d43beca
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

FLNA ANK3 LAMA4 ZNF462 SSC5D SPHKAP CTNNA3

1.67e-06200126709537dc25f8b8b4654a7c183827ee1522a41a4e0
ToppCellASK454-Epithelial-Type_2|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq

ATP8B3 LARS2 NAV2 ANGPTL7 CEP97 PLXNA1

2.50e-061361266ff9a5e111993fdb3ac64c5ef269e3460ff994517
ToppCellAdult-Epithelial-lung_goblet_cell-D175|Adult / Lineage, Cell type, age group and donor

MARK1 SHC4 MUC16 EYA2 PLCB4 RIMS1

7.34e-0616412666e6aedb61f8e195d52e028fdda750a29bb14e57e
ToppCellE18.5-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|E18.5-samps / Age Group, Lineage, Cell class and subclass

ADAMTS2 DTNA FREM1 PTPRD PNMA2 MACF1

7.34e-061641266519ab4fe885dfe4c50846f346a062acc2cb44299
ToppCellASK428-Immune-B_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq

FAM114A1 MUC16 SCRN1 SNX33 PIKFYVE RIMS1

1.06e-051751266e0979e5795a49b4e5c9b88e7fe6b7bda7a413a6c
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DPY19L1 DTNA NGEF NAV2 BCAR3 PARD3

1.17e-051781266a0ab20c588e7d43d0320d4779d9ab95c1c86e297
ToppCellfacs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLNA MARK1 DTNA KCNB1 SCN3A BCAR3

1.21e-0517912668da6863edc756540bb097cc7221c1408640d9bb4
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ANK3 MUC16 SGSM2 IFFO2 MACF1 RIMS1

1.21e-0517912666e965e424eebef50f0202cff75f458be395cfca1
ToppCellfacs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLNA MARK1 DTNA KCNB1 SCN3A BCAR3

1.21e-051791266f39c13c99a07d009cc677e363ffe089089c64916
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DPY19L1 LRP1B LHX2 SULF2 NGEF ARHGAP25

1.21e-051791266b35a7f8115c997c390201da01d7cb10b10769aec
ToppCellPND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MUC16 SULF2 PTPRD SGSM2 LRP2 NAV2

1.29e-051811266330d4322f4c4373f706273c1f4e218b59051b7fd
ToppCellPND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MUC16 SULF2 PTPRD SGSM2 LRP2 NAV2

1.29e-0518112663f4d5d79c1286614514b0e8134079d6128a2a23e
ToppCellControl-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations)

ANK3 EYA2 PTPRD NAV2 RP1 PARD3

1.29e-051811266c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCellpdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

CCDC170 DTNA LAMA4 ZNF462 NAV2 PLCB4

1.33e-0518212667b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

LRP1B SPATC1 PTPN4 RP1 GOT1 DNMT3A

1.33e-051821266041bc819e6cf2618bf86bce8dfe2df673f392ba3
ToppCellMild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)

FLNA ANK3 PIKFYVE FAM20C MACF1 ARHGAP25

1.37e-051831266278064c9f0582463b83bf156d34e77f60187613b
ToppCellwk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

RASGRF1 SCRN1 ZNF711 ALKBH8 CTNNA3 ANGPTL7

1.41e-0518412664e3ba64692868563a579902aa9c6f88cab5bce26
ToppCellP03|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

FLNA ADAMTS2 FREM1 PTPRD NAV2 MACF1

1.46e-051851266a07dbe1f76e40734a28826423a5cc64b8e56af5e
ToppCellP28-Epithelial-alveolar_epithelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

PI4K2B ANK3 MTHFD1 RABGAP1L LRP2 NAV2

1.46e-0518512665bb513e569f3a197d55ae2ca683e202daebabeac
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DPY19L1 LHX2 SULF2 SPHKAP NGEF ARHGAP25

1.46e-051851266a1b2525da018abe458908cab7268bd403ee98d92
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DTNA ZNF462 PTPRD NGEF LRP2 PARD3

1.50e-051861266f28d72b47624b69a580b4429e2be560a26898591
ToppCellLA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper

FLNA DTNA SCN3A MACF1 PLCB4 RIMS1

1.60e-05188126634e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCellfacs-MAT-Fat-3m|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMEM204 ADAMTS2 LARS2 SULF2 ELMO2 PLD1

1.60e-0518812667da9750255efbc5cf9aed7e3105a337fac63b9f0
ToppCellLA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper

FLNA DTNA SCN3A MACF1 PLCB4 RIMS1

1.65e-0518912666b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

DTNA SCGN PTPRD LRP2 PLCB4 PARD3

1.65e-05189126628b502611829e4a24caff2562545c7db97686099
ToppCellE18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass

FLNA LAMA4 FREM1 PTPRD PNMA2 MACF1

1.65e-0518912660c18d3de4720759cf802eefb4d0ddde2a9246a1a
ToppCelldroplet-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

TMEM204 ADAMTS2 PTPRD CPQ SCN3A MACF1

1.75e-05191126644a9a6768084dafc641ad455b65862bfd4cc0cb9
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ANK3 DTNA EYA2 PTPRD LRP2 PARD3

1.75e-0519112663c464645d0e7e423f791bd63bf5bcf11f6b590d3
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ANK3 DTNA EYA2 PTPRD LRP2 PARD3

1.75e-0519112661c1d13144259b998d4a0e85142f7afef2ef1e63f
ToppCellfacs-Lung-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ADAMTS2 LAMA4 PTPRD CPQ SCN3A MACF1

1.75e-051911266094c9d3270fc1e487ccf10fb4936af5f081f6009
ToppCellPND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass

DTNA FREM1 PTPRD PNMA2 NAV2 MACF1

1.75e-051911266e7c605b56934d1383237c1f946dbccef25d91368
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ADAMTS2 DTNA LAMA4 FREM1 NAV2 MACF1

1.75e-0519112666688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCellfacs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FAM114A1 ADAMTS2 LAMA4 SSC5D SULF2 CPQ

1.80e-051921266beac6b3c191b11add8e39e8d04562b478ea8929e
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ADAMTS2 DTNA LAMA4 FREM1 NAV2 MACF1

1.80e-05192126699ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCellPND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ADAMTS2 LAMA4 PTPRD CPQ SCN3A MACF1

1.85e-051931266ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7
ToppCellEpithelial-club_cell|World / Lineage, Cell type, age group and donor

ANK3 SHC4 PTPRD NAV2 RP1 RIMS1

1.85e-0519312662bdd09004fa433550958ec42ba4b06271a4aaf7c
ToppCellPND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ADAMTS2 LAMA4 PTPRD CPQ SCN3A MACF1

1.85e-05193126630481fb01c7acf85beae10213f038da86bed6777
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Newborn-22|World / Primary Cells by Cluster

DPY19L1 RPS24 ZNF462 CCDC88C PTPN4 PTPRD

1.85e-0519312663b927d4b8ecb21a408424ef91a23746c21741f49
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ADAMTS2 DTNA LAMA4 EYA2 FREM1 PTPRD

1.91e-05194126660622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ADAMTS2 DTNA LAMA4 EYA2 FREM1 PTPRD

1.91e-05194126689b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCellIPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class

ANK3 NAV2 PLCB4 RP1 PARD3 SPAG17

1.96e-051951266fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCellIPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class

ANK3 NAV2 PLCB4 RP1 PARD3 SPAG17

1.96e-05195126621dbdc803c6947024dc2416e9e21c2ef0af9bc31
ToppCellIPF-Multiplet|IPF / Disease state, Lineage and Cell class

ANK3 NAV2 PLCB4 RP1 PARD3 SPAG17

1.96e-051951266eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCellBronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations

ANK3 PTPRD RABGAP1L NAV2 PARD3 MBD5

2.02e-051961266ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCellTracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SCGN LHX9 LHX2 SPHKAP SCN3A ALPK3

2.02e-05196126695544097577f20ed7f4144bd940471cde0617554
ToppCellBronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FLNA DTNA LAMA4 LRP1B CTNNA3 PLCB4

2.02e-0519612669830fb3da7a60f65ad463e9054bb77c06b025e4d
ToppCellIPF-Epithelial|IPF / Disease state, Lineage and Cell class

ANK3 EYA2 NAV2 RP1 PARD3 SPAG17

2.02e-05196126687d9881cfec461a5d89b688a83749b618c519485
ToppCellPND03-Mesenchymal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FLNA FAM114A1 ADAMTS2 LAMA4 PTPRD MACF1

2.08e-051971266e3053ef8f604b6892c21c03e12612b49d3d30f23
ToppCellParenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ANK3 SHC4 EYA2 PTPRD RP1 RIMS1

2.14e-051981266af399569c718f5fd971d73a7926768c9311002a3
ToppCellParenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations

ANK3 PTPRD RABGAP1L NAV2 PARD3 MBD5

2.14e-0519812661996373bdccc55aac347d349bd22f6aad6d0c668
ToppCellBronchial-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SHC4 MUC16 EYA2 RIMS1 PLD1 GOT1

2.20e-051991266f5c3561744e2a0e7716657cb521acb1d8f054b41
ToppCellBronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FLNA MARK1 DTNA LAMA4 CTNNA3 PLCB4

2.26e-052001266a66449b22b39dd6987fc2c3ed160d24564234ced
ToppCellNeuronal-Excitatory-eB(RORB)-SEMA3E-|Neuronal / cells hierarchy compared to all cells using T-Statistic

DPY19L1 LRP1B LHX2 SULF2 NGEF ARHGAP25

2.26e-0520012661a3d29a580d1b405a74869a1da3e818c581fc559
ToppCellNeuronal-Excitatory-eB(RORB)-SEMA3E---L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic

DPY19L1 LRP1B LHX2 SULF2 NGEF ARHGAP25

2.26e-0520012666f9ed8fe9cda91185c3a1a675353e11b8fec6ef1
ToppCellNeuronal-Excitatory-eB(RORB)-SEMA3E--|Neuronal / cells hierarchy compared to all cells using T-Statistic

DPY19L1 LRP1B LHX2 SULF2 NGEF ARHGAP25

2.26e-05200126686705dfc05b3e1576543b93883c88fb55b742855
ToppCellNeuronal-Excitatory-eB(RORB)-SEMA3E|Neuronal / cells hierarchy compared to all cells using T-Statistic

DPY19L1 LRP1B LHX2 SULF2 NGEF ARHGAP25

2.26e-052001266db194b4f524fd008b3c5b4b6014b436190a1b87a
ToppCellEntopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32

ANXA11 NT5C1B WDR87 RP1

4.66e-057012642121ba6a0beb2a8fdc589ff1063e7d8c2c3c68f6
ToppCellEntopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32

ANXA11 NT5C1B WDR87 RP1

4.66e-05701264cd6bca68fe52f451716fc8c0b1745984bc9ec057
ToppCellEntopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)|Entopeduncular / BrainAtlas - Mouse McCarroll V32

ANXA11 NT5C1B WDR87 RP1

4.66e-05701264be300c0447735aba89df4c3082b81eb5abf22770
ToppCellParenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_systemic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

MARK1 PTPN21 ZNF462 KCNB1 PLCB4

5.07e-051411265dcc56aef1b31bfe0de84cb0b5c77d242681cf19c
ToppCell10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

LAMA4 LRP1B KCNB1 SCN3A CEP97

7.94e-05155126577fdae85d36efb776db977eb424b32487ef222e4
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CCDC170 FAM20C KCNB1 PKIB BCAR3

8.44e-051571265f896997490bb2eec598c6581f161220e70f9a991
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Batf3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

DPY19L1 LHX2 SULF2 PKIB ARHGAP25

8.44e-051571265921805932f7974d37aed547861d555b07f30aba6
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CCDC170 FAM20C KCNB1 PKIB BCAR3

8.44e-05157126514a8516346a89a89f1119b744625bd9844a74a03
ToppCelldroplet-Heart-nan-24m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FAM114A1 FAM20C ALKBH8 CEP97 PLXNA1

8.96e-0515912657ad3a91d29639b32f6264c91f401c14a35469ac0
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DTNA LRP1B FREM1 SPHKAP LRP2

9.22e-051601265c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DTNA LRP1B FREM1 SPHKAP LRP2

9.22e-05160126525c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCellmild_COVID-19_(asymptomatic)-B_intermediate|World / disease group, cell group and cell class (v2)

RASGRF1 PIKFYVE PNMA2 ARHGAP25 BCAR3

9.22e-0516012656722934e153b72039c3c4308557d0ef879a30638
ToppCellP07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

FREM1 LHX9 PTPRD NAV2 MACF1

9.50e-051611265b19f82dd98a3064581793711bb70373f18abecd9
ToppCellwk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

FLNA DTNA CPT1B LRP1B NGEF

1.01e-0416312651e8730d75cccf7292010683ab4e81a69d8e3bfa9
ToppCellChildren_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

SCGN CDH20 SPHKAP CTNNA3 RIMS1

1.04e-041641265be49af6335f2505065cde2cb9800e4a5516811b1
ToppCell368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells)

MUC16 KCNB1 PNMA2 LRP2 RIMS1

1.10e-0416612654d63c758d46e73311b864148c646bf081498dee7
ToppCell368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells)

MUC16 KCNB1 PNMA2 LRP2 RIMS1

1.10e-0416612654160ccf9291072a6e2782f9ad141bc9a9747f3ad
ToppCellVE-Treg-exh_CD4|VE / Condition, Cell_class and T cell subcluster

VIL1 RNF214 CDH20 C1QTNF4 STX10

1.13e-0416712651036ac1ef9440612500137af9d1929672b077e4d
ToppCell356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)

GPRASP1 VPS33A ZNF485 CEP350 PLD1

1.19e-041691265b66ffc2b2b6bfcc3a6e639d9d31d3de95f4a94e1
ToppCelldroplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DNAAF4 SNX33 SULF2 GVINP1 CDK13

1.19e-0416912655f5bec13208f4c3b6eacbba180c8a6402743b76e
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CCDC170 MUC16 CCDC88C RP1 SPAG17

1.19e-04169126514aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCellfacs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LARS2 LRP1B SCN3A LRP2 RP1

1.19e-04169126512bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell390C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

FAM114A1 ZNF577 RNF214 NAV2 PLXNA1

1.30e-04172126584d16cd7f618c94888920680bdc9e7130d73fd75
ToppCellmild_COVID-19_(asymptomatic)-B_memory|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)

ANK3 RASGRF1 EYA2 NT5C1B ARHGAP25

1.33e-0417312659082ad77b44f65b72094df6e502cce81b62fe81a
ToppCellASK428-Immune-B_cell|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq

ZNF577 MUC16 SNX33 PIKFYVE RIMS1

1.37e-041741265b5a7a612a515736cf3489afd0f6ad2054d54526f
ToppCellAdult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor

MUC16 EYA2 CTNNA3 PLCB4 RIMS1

1.37e-0417412657d2f802f493f19a068e097b2909a9000e2160266
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L6_LAMP5_C1QL2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

TMEM204 DGKD FREM1 SPHKAP PLXNA1

1.40e-0417512654d42a97c450e919a409477a7db85e2668f0d473b
ToppCell356C-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells)

ANK3 LAMA4 NAV2 PLCB4 RPA4

1.40e-0417512657de1023161233b64f11e130881c742f4cf2bff65
ToppCellE16.5-Epithelial-Epithelial_Airway-Neurosecretory|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

VIL1 SCRN1 PNMA2 PKIB PLXNA1

1.40e-04175126538dec78efc99fe23479cba68cfa441e62bd6a08b
ToppCellfacs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SCGN LRP1B FREM1 LRP2 BCAR3

1.40e-041751265887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RPS24 LRP1B FREM1 LRP2 BCAR3

1.44e-041761265c6484334187f64cd00cd35e77d8ae436556b4260
ToppCellPND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MUC16 SULF2 PNMA2 LRP2 ANGPTL7

1.44e-0417612658e7f38de8bf68077e2138f4d06c1f55b0fd096cc
ToppCellPND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MUC16 SULF2 PNMA2 LRP2 ANGPTL7

1.44e-041761265ed575330a08a6748ea4b28433292c8cfd157d444
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ADAMTS2 SULF2 CDH20 SPHKAP LRP2

1.48e-041771265a25ca82c4bda033ee113f8ecb4a541b22e7a29ca
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ADAMTS2 SULF2 CDH20 SPHKAP LRP2

1.48e-041771265fbead6e56271b1f1d447f89857de444ebe7157b0
ToppCellE16.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

VIL1 SCRN1 PNMA2 PKIB PLXNA1

1.52e-041781265d3a75a8082e70543b84c35d53fe77625300d19fa
DrugSulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A

LPAR4 DTNA PTPN21 CPT1B TBX19 BAZ2A CDK13 LRP2 DNMT3A

1.28e-0619412593422_UP
DrugDNA-PK Inhibitor III; Up 200; 1uM; PC3; HT_HG-U133A

LAMA4 PTPN21 CPT1B SGSM2 LRP2 ZER1 RIMS1 PLD1

1.12e-0519212587548_UP
DrugMetaraminol bitartrate [33402-03-8]; Down 200; 8.6uM; PC3; HT_HG-U133A

LAMA4 KCNB1 BAZ2A ELMO2 CDK13 RABGAP1L PNMA2 RPA4

1.25e-0519512583669_DN
DrugClemastine fumarate [14976-57-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A

DTNA ANXA11 LHX2 BAZ2A CDK13 SAFB2 ZER1 DNMT3A

1.30e-0519612587485_DN
DrugAld1.1-H_000455; Up 200; 10uM; PC3; HT_HG-U133A

GPRASP1 TOM1 ABCF2 POGZ PTPN21 CPT1B ZER1

9.07e-0519112577547_UP
DrugThioguanosine [85-31-4]; Up 200; 12.6uM; PC3; HT_HG-U133A

CCDC170 RASGRF1 DTNA ABCF2 PTPN21 ALPK3 PLD1

9.68e-0519312576643_UP
DrugBenzethonium chloride [121-54-0]; Down 200; 9uM; MCF7; HT_HG-U133A

DTNA ABCF2 URB2 PTPN21 SAFB2 ZER1 DNMT3A

1.00e-0419412576070_DN
DrugHydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; PC3; HT_HG-U133A

LPAR4 ABCF2 NUP214 CPT1B SGSM2 ZER1 SMG6

1.00e-0419412576660_DN
DrugClomipramine hydrochloride [17321-77-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A

TOM1 ABCF2 PTPN21 RABGAP1L SAFB2 STX6 DNMT3A

1.03e-0419512576825_DN
DrugEtofenamate [30544-47-9]; Down 200; 10.8uM; MCF7; HT_HG-U133A

DTNA EYA2 BRCA1 BAZ2A ZER1 PARD3 CEP97

1.03e-0419512577327_DN
DrugPiracetam [7491-74-9]; Down 200; 28.2uM; MCF7; HT_HG-U133A

ANK3 ABCF2 CPT1B BAZ2A SAFB2 MACF1 KDM2A

1.07e-0419612575462_DN
DrugTimolol maleate salt [26921-17-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A

DTNA CPT1B EHBP1L1 LRP2 PLD1 RPA4 PLXNA1

1.07e-0419612575280_DN
DrugMiconazole [22916-47-8]; Down 200; 9.6uM; PC3; HT_HG-U133A

DTNA VPS33A LAMA4 CEP350 RABGAP1L PLD1 SMG6

1.07e-0419612576615_DN
DrugDroperidol [548-73-2]; Down 200; 10.6uM; PC3; HT_HG-U133A

LAMA4 TBX19 BAZ2A RABGAP1L PLD1 PKD1L1-AS1 STX6

1.07e-0419612574629_DN
DrugDantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A

DTNA ABCF2 POGZ BRCA1 BAZ2A CDK13 ZER1

1.07e-0419612572329_DN
DrugDiflorasone Diacetate [33564-31-7]; Down 200; 8uM; MCF7; HT_HG-U133A

VPS33A PTPN21 CPT1B NAV2 ZER1 PARD3 PLXNA1

1.07e-0419612572798_DN
DrugIodipamide [606-17-7]; Up 200; 3.6uM; MCF7; HT_HG-U133A

DTNA LAMA4 NUP214 PTPRD BAZ2A SAFB2 MACF1

1.07e-0419612575510_UP
DrugOxantel pamoate [68813-55-8]; Up 200; 6.6uM; MCF7; HT_HG-U133A

URB2 PTPN21 NAV2 ZER1 PARD3 CEP97 DNMT3A

1.07e-0419612575338_UP
DrugHarmaline hydrochloride dihydrate [6027-98-1]; Down 200; 14uM; MCF7; HT_HG-U133A

DTNA NUP214 PTPN21 CEP350 BAZ2A SAFB2 DNMT3A

1.10e-0419712574968_DN
DrugProcyclidine hydrochloride [1508-76-5]; Down 200; 12.4uM; PC3; HT_HG-U133A

ANK3 DTNA PTPN21 ZNF711 BRCA1 CDK13 ZER1

1.10e-0419712574233_DN
DrugTriamcinolone [124-94-7]; Up 200; 10.2uM; PC3; HT_HG-U133A

ABCF2 NUP214 BAZ2A CDK13 SGSM2 NAV2 ZER1

1.10e-0419712575835_UP
Drugvinblastine sulfate; Up 200; 0.1uM; MCF7; HT_HG-U133A

ANK3 DTNA VPS33A LAMA4 DGKD PTPN21 STX6

1.10e-0419712577551_UP
DrugLY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A

VPS33A ABCF2 CPT1B SAFB2 ZER1 PARD3 DNMT3A

1.10e-0419712575576_DN
DrugBepridil hydrochloride [74764-40-2]; Down 200; 10uM; PC3; HT_HG-U133A

GPRASP1 VPS33A LAMA4 PTPN21 CPQ BAZ2A ELMO2

1.10e-0419712574613_DN
DrugCefixime [79350-37-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A

DTNA DGKD ECPAS BAZ2A CDK13 LRP2 ZER1

1.10e-0419712573247_UP
DrugSpectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; PC3; HT_HG-U133A

LPAR4 DTNA LAMA4 NUP214 CPT1B LHX2 SAFB2

1.14e-0419812574187_DN
DrugAtropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; PC3; HT_HG-U133A

LPAR4 DTNA ABCF2 CCDC88C SAFB2 STX6 SMG6

1.14e-0419812575865_UP
DrugRifampicin [13292-46-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A

TOM1 CEP350 TBX19 CCDC88C SAFB2 PARD3 DNMT3A

1.14e-0419812572847_DN
DrugMexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; HL60; HT_HG-U133A

DTNA RALGAPB BAZ2A SAFB2 MACF1 ARHGAP25 PKD1L1-AS1

1.14e-0419812572364_DN
DrugMetixene hydrochloride [1553-34-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A

DTNA CEP350 EHBP1L1 SAFB2 KDM2A PARD3 PLXNA1

1.14e-0419812573313_DN
DrugLomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; HL60; HT_HG-U133A

DTNA BAZ2A TRNAU1AP PLCB4 PKD1L1-AS1 CEP97 PLXNA1

1.14e-0419812572348_DN
DrugNisoxetine hydrochloride [57754-86-6]; Up 200; 13uM; MCF7; HT_HG-U133A

DTNA LAMA4 ECPAS KCNB1 SAFB2 PARD3 DNMT3A

1.14e-0419812576496_UP
Drugrotenone; Down 200; 1uM; MCF7; HT_HG-U133A

GPRASP1 ABCF2 LHX2 EHBP1L1 RABGAP1L ZER1 DNMT3A

1.14e-0419812575915_DN
DrugZoxazolamine [61-80-3]; Up 200; 23.8uM; MCF7; HT_HG-U133A

LAMA4 ABCF2 NUP214 EHBP1L1 BAZ2A PARD3 DNMT3A

1.17e-0419912572625_UP
DrugMethapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A

LPAR4 ABCF2 NUP214 ECPAS PARD3 PKD1L1-AS1 RPA4

1.17e-0419912574990_UP
DrugNortriptyline hydrochloride [894-71-3]; Down 200; 13.4uM; HL60; HT_HG-U133A

FAM114A1 DTNA CPQ SAFB2 MACF1 RPA4 PLXNA1

1.17e-0419912572391_DN
DrugLisuride (S)(-) [18016-80-3]; Down 200; 11.8uM; PC3; HT_HG-U133A

LAMA4 ABCF2 SAFB2 ZER1 PLD1 PLXNA1 SMG6

1.17e-0419912576682_DN
Drugalpha-Santonin [481-06-1]; Down 200; 16.2uM; PC3; HT_HG-U133A

TOM1 LAMA4 BRCA1 CPQ PARD3 PKD1L1-AS1 STX6

1.17e-0419912574531_DN
DrugHydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A

ABCF2 PTPN21 TBX19 BRCA1 BAZ2A SAFB2 LRP2

1.17e-0419912575494_DN
DrugCorynanthine hydrochloride [66634-44-4]; Up 200; 10.2uM; PC3; HT_HG-U133A

CCDC170 DTNA PTPN21 CEP350 RABGAP1L LRP2 PLD1

1.21e-0420012574227_UP
Diseasedevelopmental cardiac valvular defect (is_implicated_in)

MTHFD1 PLD1

1.67e-0521212DOID:0080633 (is_implicated_in)
DiseaseDNA methylation

ADAMTS2 SRP9 LRP1B FREM1 LHX9 POLR1D CPQ MROH2B RABGAP1L RIMS1 PARD3

8.44e-0565612111GO_0006306
Diseaseneuroimaging measurement

ANK3 PTPN21 ZNF462 CCDC88C PTPN4 SULF2 SEC14L6 BRCA1 NAV2 MACF1 PLD1 PARD3 STX6 SMG6

1.27e-04106912114EFO_0004346
Diseasebreast size

CCDC170 MARK1 PTPN4 SPAG17

1.89e-04691214EFO_0004884
Diseaseprostate-specific antigen measurement, disease progression measurement

SPHKAP NGEF

3.46e-0471212EFO_0008336, EFO_0020660
Diseasetotal cholesterol measurement, response to escitalopram, response to citalopram

ARHGAP25 RIMS1

4.59e-0481212EFO_0004574, EFO_0006329, EFO_0007871
DiseaseIntellectual Disability

POGZ ZNF462 ALKBH8 BRCA1 SCN3A LRP2 MACF1 DNMT3A

5.28e-044471218C3714756
Diseaseneuritic plaque measurement

ANK3 FREM1 SULF2 MROH2B SPATA16 RP1 RIMS1

6.08e-043491217EFO_0006798
Diseasesexual dimorphism measurement

VIL1 RASGRF1 DNAAF4 VPS33A HNRNPM ZNF462 RNF214 SSC5D EHBP1L1 ALPK3 MACF1 KDM2A DNMT3A

6.25e-04110612113EFO_0021796
DiseaseCOVID-19, mortality

DTNA LRP1B CPQ CTNNA3 LRP2

6.94e-041701215EFO_0004352, MONDO_0100096
Diseasemigraine disorder

ZNF462 PTPRD CPQ RABGAP1L CTNNA3 MACF1 SMG6

6.95e-043571217MONDO_0005277
DiseaseMitral valve prolapse, response to surgery

ALPK3 SMG6

1.07e-03121212EFO_0009951, HP_0001634
Diseaselongevity

POGZ ALKBH8 MTHFD1 SPATA16 RABGAP1L RP1

1.15e-032841216EFO_0004300
Diseaseperipheral arterial disease, traffic air pollution measurement

NAV2 MACF1 RIMS1 MBD5 GOT1

1.25e-031941215EFO_0004265, EFO_0007908
Diseasecardiomyopathy (biomarker_via_orthology)

GOT1 ATP5F1B

1.26e-03131212DOID:0050700 (biomarker_via_orthology)
Diseasecortisol measurement, response to corticosteroid, response to synacthen

SCGN LRP1B

1.26e-03131212EFO_0005843, EFO_0009175, GO_0031960
Diseasereticulocyte measurement

VIL1 FLNA EYA2 ECPAS PIKFYVE CDH20 ARHGAP25 C1QTNF4 PLD1 ATP5F1B DNMT3A SMG6

1.32e-03105312112EFO_0010700
DiseaseProteinuria

LRP2 SMG6

1.69e-03151212HP_0000093
Diseasethird ventricle volume measurement

ANK3 PTPRD

1.69e-03151212EFO_0010335
Diseaseadverse effect, response to xenobiotic stimulus

LRP1B CTNNA3 NAV2

1.85e-03591213EFO_0009658, GO_0009410
Diseasedecreased susceptibility to hepatitis C infection

PTPRD NAV2

1.93e-03161212EFO_0010101
Diseasebrain measurement, neuroimaging measurement

ANK3 ZNF462 CCDC88C SEC14L6 NAV2 MACF1 PARD3 SMG6

1.98e-035501218EFO_0004346, EFO_0004464
DiseaseAcute myeloid leukemia

NUP214 DNMT3A

2.18e-03171212cv:C0023467
DiseaseLEUKEMIA, ACUTE MYELOID

NUP214 DNMT3A

2.18e-03171212601626
Diseaseresponse to antiviral drug

SHC4 PKIB

2.44e-03181212EFO_0010123
Diseasesevere acute respiratory syndrome, COVID-19

ATP8B3 LRP1B POLR1D PTPN4 PTPRD PARD3 STX6

2.51e-034471217EFO_0000694, MONDO_0100096
DiseaseEpstein-Barr virus infection

CCDC170 CPQ CTNNA3

2.55e-03661213EFO_0000769
Diseaseperipheral neuropathy, response to docetaxel trihydrate

SPHKAP CTNNA3

2.72e-03191212EFO_0003100, GO_1902519
DiseaseJuvenile Myelomonocytic Leukemia

ASXL1 DNMT3A

2.72e-03191212C0349639
DiseaseCraniosynostosis

FREM1 ZNF462

3.02e-03201212C0010278
Diseasebreast carcinoma

CCDC170 ZNF577 SCGN CCDC88C PTPRD SEC14L6 CTNNA3 PKIB SPAG17 DNMT3A SMG6

3.19e-03101912111EFO_0000305
Diseasestomach cancer (is_implicated_in)

LRP1B BRCA1 DNMT3A

3.26e-03721213DOID:10534 (is_implicated_in)
DiseaseBipolar Disorder

ANK3 RASGRF1 TOM1 LARS2 MTHFD1 RIMS1 MBD5

3.59e-034771217C0005586
Diseasehair colour measurement

ASXL1 TOM1 SHC4 LHX2 NGEF BCAR3 PARD3 PLXNA1

3.91e-036151218EFO_0007822

Protein segments in the cluster

PeptideGeneStartEntry
KMKRTLMQTSFRSEG

URB2

681

Q14146
ITMMRGSQESSLRKT

NT5C1B

96

Q96P26
AEAMNKESPMVRSAR

SMG6

356

Q86US8
QTFRKDMSEMSIDRN

ERICH6

141

Q7L0X2
MMASGLTERVVSDKT

ABCF2

366

Q9UG63
TGSEKARAIMEEVMS

CPQ

376

Q9Y646
MTGRDIEKSICREMS

ANXA11

401

P50995
TNIESMKMEGSRGRL

DNMT3A

156

Q9Y6K1
ILGVSEEMRRNMGVS

BCAR3

566

O75815
SVQRSLVEQMRDMGS

ALKBH8

536

Q96BT7
RRSSRIMEETSGMEE

BAZ2A

1041

Q9UIF9
AISSEEKTQRMSLMR

GVINP1

761

Q7Z2Y8
DKEATMTNISGQRMR

GVINP1

1176

Q7Z2Y8
DRSAQKGMMTQGRAE

ALPK3

856

Q96L96
KGMMTQGRAETQLET

ALPK3

861

Q96L96
DGASRRREMQSQSVM

C1QTNF4

261

Q9BXJ3
VLAIMDFNSTRKRMS

ATP8B3

631

O60423
RRTQMETEMGGISTT

PKD1L1-AS1

81

Q9H7B7
RRQKQMGMTDDVSTI

CDK13

1026

Q14004
VNGDMRLVTRTDGMV

ASXL1

1046

Q8IXJ9
SRETGEVVSMKRMVH

ADAMTS2

661

O95450
ATDMGTMQERITTTK

ATP5F1B

336

P06576
SSMVVMLTTQVERGR

PTPN4

746

P29074
MRTDSSKMTDVESGV

PKIB

1

Q9C010
VMELESNSKRMESRL

ANGPTL7

81

O43827
SISTRMVMIEEFKQG

PAPOLB

331

Q9NRJ5
DMRRTGSRKFNTMES

MUC16

12246

Q8WXI7
MDGMNRTRIIDSKTE

LRP1B

356

Q9NZR2
FRMKMRSETAIFITN

LPAR4

66

Q99677
ASSIERMGQTMERIG

HNRNPM

466

P52272
ELDRMTRKPDSMVTN

DYNC1LI2

471

O43237
MRFTSTKLAQMEREN

CCDC88C

716

Q9P219
KGMMSTVTEVRALSI

ECPAS

1261

Q5VYK3
FSMRDRGNVASLIMT

PLXNA1

1381

Q9UIW2
QGIMEEMERRSKTEA

LHX9

31

Q9NQ69
KAEIAMNMGETRIIS

FREM1

1281

Q5H8C1
LSTLEREMAFRTEMG

DPY19L1

51

Q2PZI1
AGMAEARVLMTRKTE

EHBP1L1

856

Q8N3D4
VGTSEEMKMLRTESD

NUP214

731

P35658
GISASEMVMRARDLV

LHX2

121

P50458
RASMDGSMRTVIVQD

LRP2

1581

P98164
RIMSVDEQKSLMVTG

PNMA2

11

Q9UL42
KSSLEATREMVTRFM

MACF1

4166

Q9UPN3
RNEVEALRAMATMKS

RABGAP1L

146

Q5R372
DAEKRMMDSSPVRTT

PTPN21

766

Q16825
IQRSTETGMAAEMRK

RIMS1

1466

Q86UR5
KATFESQMSVMRGQI

PI4K2B

411

Q8TCG2
ASTERVNKRMSMVVS

BRCA1

1641

P38398
KMISESGSRMDVLAR

CTNNA3

736

Q9UI47
ERISRMTQGDLVMSM

PIKFYVE

781

Q9Y2I7
NDVKMCVGSRRMVDV

KDM2A

96

Q9Y2K7
LERAKRNGSIVSMNM

KCNB1

436

Q14721
VLGRMSDQTDSVRFM

BTAF1

1191

O14981
RTQSSNMETRLDAMK

ELMO2

91

Q96JJ3
GRMVNMTKEIRDVTR

FAM20C

331

Q8IXL6
RVTGDDSMRMSHLKV

FLNA

1951

P21333
GVIRTALMNMDREAK

CDH20

221

Q9HBT6
MMRSEINTEVNEKAG

CEP97

466

Q8IW35
GASMRTEEEMPNRTK

CEP350

216

Q5VT06
TGNVKTMADRILTMR

GOT1

321

P17174
MTRSGAIDMSKRDFV

ANK3

3611

Q12955
SMKRGLDVQMETCRR

IFFO2

461

Q5TF58
NDTKRIDIMVTMGFA

MARK1

331

Q9P0L2
RTMMSFKERLENTVE

MBD5

1271

Q9P267
LSVTGVDKEMMQRIR

DNAAF4

86

Q8WXU2
AVFGSMQMAVSRVIR

DGKD

876

Q16760
MIEDSGKRGNTMAER

DTNA

1

Q9Y4J8
MGITTMDRVTTGRNE

CCDC196

241

A0A1B0GTZ2
RARNMIEVVTSEMKT

CCDC170

621

Q8IYT3
TIEGEEAMRIKMRSS

CCDC168

3986

Q8NDH2
FMTTQDASKDGRIRM

SCGN

66

O76038
KTKMGERQRAREMTE

SEC14L6

321

B5MCN3
VTISVDGKMMTIRTE

FABP9

41

Q0Z7S8
RVMVKASNRMSSVVS

PKD1L1

566

Q8TDX9
TTSLEDMRERLGKMV

MTHFD1

576

P11586
ASMTRMFREGRTETV

CPT1B

591

Q92523
DAVFVRSMKRSVMTL

LRRC72

241

A6NJI9
MERTVSLSQMLREAK

FAM114A1

256

Q8IWE2
QDAMETLRRSMSTEG

PARD3

656

Q8TEW0
QRSATVVMMTKLEER

PTPRD

1446

P23468
RSVASKIQVSMMFDG

LAMA4

826

Q16363
NQDGTMTVEMKVRFR

RP1

326

P56715
KDTTTSVRIGLMMEE

EYA2

296

O00167
TSMAEGERKTALEMV

POLR1D

16

P0DPB6
KIAMGMRSASQFTRD

GPRASP1

1176

Q5JY77
DSMNRRIMETASKSQ

SPHKAP

641

Q2M3C7
RAFATMGETVMSVKI

TRNAU1AP

21

Q9NX07
EKRADQMRAMGIETS

PLCB4

846

Q15147
TISDTIARFQKMRGM

LARS2

106

Q15031
DRSMLGKRDSEMAVI

PLD1

916

Q13393
AVRKMSVMGRQTCLE

POGZ

741

Q7Z3K3
EGVRKMSRTEQMISI

NGEF

456

Q8N5V2
KLMETEISGRVRNME

NAV2

2296

Q8IVL1
KRSSIRSVDMEEMGT

SGSM2

396

O43147
VKESQRMSDEGRMVQ

SNX33

496

Q8WV41
RQVVRDMKDQMSTSS

STX6

96

O43752
GLTREDTVRQMETMG

SPATA16

416

Q9BXB7
ISMEMLEDSSGRQRA

SCN3A

691

Q9NY46
RERTTKTMAMLTTQG

SSC5D

706

A1L4H1
QTMLRLAEDERMKGT

MROH2B

136

Q7Z745
QMIKRTREGTREAEM

RASGRF1

606

Q13972
VQTMMNTLRDKASGV

SCRN1

251

Q12765
QEMMVKDSRTEEERG

SPAG17

1801

Q6Q759
EVLQSMRSLDFGMRT

SHC4

201

Q6S5L8
MRSLDFGMRTQVTRE

SHC4

206

Q6S5L8
IKTARTTMAGLTMEE

RNF214

581

Q8ND24
AVEGINRMTRALMDS

TOMM34

121

Q15785
ESTRMERLRGMTLAK

VIL1

181

P09327
EREMAKMVADTISRT

VIL1

566

P09327
MATARQETKEMARKV

ZER1

736

Q7Z7L7
MMLDKARRDTTVESV

RPA4

166

Q13156
RTTEPSTKSMMEVER

SPATC1

406

Q76KD6
RSELEMVSGNVRVMS

TOM1

221

O60784
EMDHTQSRMDGVLRK

STX10

201

O60499
ARSRSVMTGEQMAAF

ARHGAP25

21

P42331
MKNATIVMSVRREQG

ZNF577

1

Q9BSK1
MNDTVTIRTRKFMTN

RPS24

1

P62847
MQRTGMNTVSAREKL

ZBED8

391

Q8IZ13
TKSGSRGMERTVVMD

SAFB2

561

Q14151
MTAITTQASMEFRRK

RALGAPB

471

Q86X10
TQASMEFRRKGSQMS

RALGAPB

476

Q86X10
EFRRKGSQMSTDTMV

RALGAPB

481

Q86X10
FRIQKTMRMVSVDRG

ZNF462

1061

Q96JM2
TMRMVSVDRGSALSQ

ZNF462

1066

Q96JM2
QESRGTVKLQFDMMR

TMEM204

86

Q9BSN7
RLMVAKEARNVTMET

SRP9

71

P49458
MIRMKREFTGSQNSI

VPS33A

206

Q96AX1
ERMRHTGTEKMASES

TOGARAM1

1206

Q9Y4F4
VCREDVMGITDRSKM

TRIM4

396

Q9C037
EVTNEMIVTKNGRRM

TBX19

56

O60806
VAGVLDQSRMQREKM

ZNF711

276

Q9Y462
GRKMSEITINSMIET

WDR87

871

Q6ZQQ6
EASVLGERTKSVMME

ZNF485

101

Q8NCK3
RKRLQTLMSVDDSME

SULF2

281

Q8IWU5